|Articles|September 13, 2016
PSI CRO Adopts goBalto Platform
PSI CRO has chosen goBalto’s end-to-end study startup platform for conducting clinical trials from site identification, feasibility and selection through to site activation.
Advertisement
PSI CRO has chosen goBalto’s end-to-end study startup platform for conducting clinical trials from site identification, feasibility and selection through to site activation. PSI CRO will apply the platform for use in a multi-country Phase II Infectious Disease Study.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Breaking the Efficacy Ceiling in IBD and Beyond
3
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5